...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and biological evaluation of new 4beta-anilino-4'-O-demethyl-4-desoxypodophyllotoxin derivatives as potential antitumor agents.
【24h】

Synthesis and biological evaluation of new 4beta-anilino-4'-O-demethyl-4-desoxypodophyllotoxin derivatives as potential antitumor agents.

机译:新型4β-苯胺基-4'-O-去甲基-4-脱氧鬼臼毒素衍生物的合成和生物学评估作为潜在的抗肿瘤药物。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of new 4beta-anilino-4'-O-demethyl-4-desoxypodophyllotoxin derivatives were prepared and evaluated for their cytotoxicities against four human cancer cell lines including KB, KB/VCR, A549 and 95D. Most compounds showed better growth-inhibition activities against tested cell lines than that of etoposide (VP-16). Preliminary structure-activity relationships (SARs) were concluded and it indicated that the side chains substituted at 4beta position of podophyllotoxin significantly influenced the cytotoxic activity, especially for the drug resistance profile. In vivo studies of compound 26c on highly metastatic human lung cancer xenograft in nude mice showed that it can significantly inhibit tumor growth with administrating by oral route.
机译:制备了一系列新的4β-苯胺基-4'-O-去甲基-4-脱氧鬼臼毒素衍生物,并评估了它们对四种人类癌细胞系(包括KB,KB / VCR,A549和95D)的细胞毒性。与依托泊苷(VP-16)相比,大多数化合物对测试细胞系的生长抑制活性更好。初步的结构-活性关系(SARs)得出结论,并表明在鬼臼毒素的4beta位置取代的侧链显着影响细胞毒性活性,特别是对于药物耐药性。化合物26c在裸鼠体内对高度转移性人肺癌异种移植物的体内研究表明,通过口服途径给药,它​​可以显着抑制肿瘤的生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号